Bought
Maintained
Sold
Other funds holding MXL
CCM
PCMI
Axa's MXL Position: Q4 2022 in Review
Axa sold out of MaxLinear (MXL) in Q4 2022, closing a stake of 11,500 shares — an estimated $375K sold.
Axa first reported a position in MXL in Q4 2015 and held it in 8 quarters. The position peaked at $2.46M in Q3 2016. 280 funds tracked by Wall St. Rank hold MXL as of Q4 2022.
- Axa reported no remaining MaxLinear position as of Q4 2022 after selling out during the quarter.
- Axa sold 11,500 MaxLinear shares in Q4 2022, an estimated $375K.
- Axa first reported a position in MaxLinear in Q4 2015 and held it in 8 quarters.
- Axa's MaxLinear position peaked at $2.46M in Q3 2016.
- 280 funds tracked by Wall St. Rank held MaxLinear as of Q4 2022.
Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.